Drugs / C-11 ER176
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04786223 | Mar 2021 → Mar 2029 expected | Alzheimer disease, Lewy body dementia | Val Lowe | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-11 ER176 | “This study is being done to research the usefulness of PET/CT imaging for measuring brain inflammation and its relation to Alzheimer's Disease Dementia and related dementias....” NCT04786223 ↗ |
| Route | Intravenous | “It will be administered at a single time IV prior to the PET imaging.” NCT04786223 ↗ |